Lack of mu-opioid receptor leads to an increase in the NMDA receptor subunit mRNA expression and NMDA-induced

C G Jang1, S Y Lee, H H Loh

  • 1Department of Pharmacology, College of Pharmacy, Sungkyunkwan University, 440-746, Suwon, South Korea.

Insights

Mu-opioid receptor knockout mice exhibit heightened sensitivity to N-methyl-D-aspartate (NMDA) induced seizures. This suggests that the absence of the mu-opioid receptor gene alters the NMDA receptor system, impacting synaptic excitability and potentially influencing conditions like epilepsy.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • The mu-opioid receptor system plays a role in modulating neuronal excitability.
  • N-methyl-D-aspartate (NMDA) receptors are critical ionotropic glutamate receptors involved in synaptic plasticity and excitability.
  • Understanding the interplay between opioid receptors and NMDA receptors is crucial for neurological research.

Purpose of the Study:

  • To investigate the functional changes in the NMDA receptor system in mu-opioid receptor gene knockout mice.
  • To determine if the absence of mu-opioid receptors affects susceptibility to NMDA-induced convulsions.

Main Methods:

  • In situ hybridization was used to quantify NMDA receptor subunit mRNA levels in specific brain regions of knockout and wild-type mice.
  • Intracerebroventricular injection of NMDA was employed to induce convulsions, and dose-response relationships (ED50) were determined.

Main Results:

  • Mu-opioid receptor knockout mice showed significant increases in NR1, NR2A, and NR2B subunit mRNA levels in various brain regions, including the parietal cortex, thalamus, and hypothalamus.
  • The ED50 for NMDA-induced convulsions was significantly lower in knockout mice compared to wild-type mice, indicating increased sensitivity.
  • Potency ratio analysis confirmed a 1.44-fold higher sensitivity to NMDA-induced convulsions in mu-opioid receptor knockout mice (P < 0.05).

Conclusions:

  • The absence of the mu-opioid receptor gene is associated with alterations in the NMDA receptor system.
  • These changes in the NMDA receptor system in knockout mice lead to increased sensitivity to NMDA-induced convulsions.
  • The findings suggest a modulatory role of the mu-opioid receptor system on NMDA receptor function, impacting synaptic excitability relevant to conditions like epilepsy.

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...